Vitamin D and cancer: Diversity, complexity, and still a ways to go

Cancer Prevention Research

Volumn 8, Issue 8, 2015, Pages 657-661

  Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; VITAMIN;

ARTICLE; BLADDER CANCER; BREAST CANCER; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COLORECTAL CANCER; GENETIC VARIABILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); VITAMIN SUPPLEMENTATION; BLOOD; COLORECTAL NEOPLASMS; COMPLICATION; FEMALE; VITAMIN D DEFICIENCY;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84942060952     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0207     Document Type: Article

References (31)

1. IOM (Institute of Medicine). Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press, 2011.
2. IARC. Vitamin D and Cancer. 2009. Lyon, France: International Agency for Research on Cancer.
3. Chandler PD, Buring JE, Manson JE, Giovannucci EL, Moorthy MV, Zhang S, et al. Circulating vitamin D levels and risk of colorectal cancer in women. Cancer Prev Res 2015;8:675-82.
4. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:56-65.
5. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-32.
6. Weinstein SJ, Purdue MP, Smith-Warner S, Mondul AM, Black A, Ahn J, et al. Serum 25-hydroxyvitamin D, vitamin D binding protein, and risk of colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Int J Cancer 2015;136:E654-64.
7. Lee JE, Li H, Chan AT, Hollis BW, Lee IM, Stampfer MJ, et al. Circulating levels of Vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res 2011;4:735-43.
8. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011;128:1414-24.
9. Trivedi D, Doll R, Khaw K. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
10. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96.
11. Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, LaCroix AZ, Anderson GL, et al. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int 2013;24:567-80.
12. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739-45.
13. Xu Y, Shao X, Yao Y, Xu L, Chang L, Jiang Z, et al. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. J Cancer Res Clin Oncol 2014;140:1465-77.
14. Albanes D, Mondul AM, Yu K, Parisi D, Horst RL, Virtamo J, et al. Circulating 25-hydroxyvitamin D and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2011;20:1850-60.
15. Weinstein SJ, Mondul AM, Kopp W, Rager H, Virtamo J, Albanes D. Circulating 25-hydroxyvitamin D, vitamin D binding protein, and risk of prostate cancer. Int J Cancer 2013;132:2940-7.
16. Mondul AM, Shui IM, Yu K, Travis RC, Stevens VL, Campa D, et al. Genetic variation in the vitamin D pathway in relation to risk of prostate cancer - results from the breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 2013;22:688-96.
17. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 2010;46:2196-205.
18. Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine 2013;92:123-31.
19. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, et al. Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008;100:1581-91.
20. Mondul AM, Shui IM, Yu K, Weinstein SJ, Tsilidis KK, Joshi A, et al. Vitamin-D associated genetic variation and risk of breast cancer in the Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2015;24:627-30.
21. Helzlsouer KJ; VDPP Steering Committee. Overview of the cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 2010;172:4-9.
22. Liao Y, Huang JL, Qiu MX, Ma ZW. Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis. Tumour Biol 2015;36:1567-72.
23. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 2010;172:81-93.
24. Wolpin BM, Ng K, Bao Y, Kraft P, Stampfer MJ, Michaud DS, et al. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2012;21:82-91.
25. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D. Impact of circulating vitamin D binding protein on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res 2012;72:1190-8.
26. Cashman KD. Vitamin D: dietary requirements and food fortification as a means of helping achieve adequate vitamin D status. J Steroid Biochem Mol Biol 2015;148:19-26.
27. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012;33:159-71.
28. Wehr E, Pilz S, Boehm BO, Marz W, Obermayer-Pietsch B. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol 2010;73:243-8.
29. Pilz S, Frisch S, Koertke H, Kuhn J, Dreier J, Obermayer-Pietsch B, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res 2011;43:223-5.
30. Mondul AM, Weinstein SJ, Kopp W, Rager H, Virtamo J, Albanes D. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer 2012;107:1589-94.
31. Mondul AM, Sampson JN, Moore SC, Weinstein SJ, Evans AM, Karoly ED, et al. Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Am J Clin Nutr 2013;98:488-93.